Daniel B. Gregson
Impact in
- Molecular Medicine top 0.2%
- Antibiotic Resistance in Bacteria
- Endocrinology top 1%
- Escherichia coli research studies
Papers in
-
- Antibiotic Resistance in Bacteria 26
-
- Antimicrobial Resistance in Staphylococcus 16
- Co-authors
- Kevin B. Laupland (48 shared papers)Deirdre L. Church (57 shared papers)Terry Ross (21 shared papers)Johann D D Pitout (26 shared papers)Sameer Elsayed (11 shared papers)Michael D. Parkins (18 shared papers)Barbara L. Chow (6 shared papers)Gisele Peirano (5 shared papers)
- Journals
- Journal of Clinical Microbiology (18 papers)BMC Infectious Diseases (8 papers)Diagnostic Microbiology and Infectious Disease (5 papers)Clinical Microbiology and Infection (5 papers)Antimicrobial Agents and Chemotherapy (5 papers)
- Partner nations
- CanadaUnited StatesAustralia
In The Last Decade
Daniel B. Gregson
120 papers receiving 5.5k citations
Peers
Comparison fields: 5 of 116
- Molecular Medicine 1.7k
- Endocrinology 391
- Applied Microbiology and Biotechnology 209
- Clinical Biochemistry 376
- Infectious Diseases 1.4k
Countries citing papers authored by Daniel B. Gregson
This map shows the geographic impact of Daniel B. Gregson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel B. Gregson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel B. Gregson more than expected).
Fields of papers citing papers by Daniel B. Gregson
This network shows the impact of papers produced by Daniel B. Gregson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel B. Gregson. The network helps show where Daniel B. Gregson may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel B. Gregson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 121 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2004 | 301 | |
| 2 | 2005 | 293 | |
| 3 | 2008 | 263 | |
| 4 | 2009 | 224 | |
| 5 | 2007 | 197 | |
| 6 | 1999 | 186 | |
| 7 | 2008 | 170 | |
| 8 | 2004 | 169 | |
| 9 | 2008 | 168 | |
| 10 | 2009 | 136 | |
| 11 | 2011 | 135 | |
| 12 | 2005 | 133 | |
| 13 | 2002 | 131 | |
| 14 | 2005 | 127 | |
| 15 | 2006 | 116 | |
| 16 | 2007 | 113 | |
| 17 | 2005 | 109 | |
| 18 | 2008 | 105 | |
| 19 | 2013 | 97 | |
| 20 | 2000 | 92 |
About Daniel B. Gregson
Daniel B. Gregson is a scholar working on Molecular Medicine, Infectious Diseases, Clinical Biochemistry, Epidemiology and Endocrinology, having authored 121 papers that have together received 5.7k indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (26 papers), Bacterial Identification and Susceptibility Testing (17 papers), Antimicrobial Resistance in Staphylococcus (16 papers), Urinary Tract Infections Management (11 papers), Sepsis Diagnosis and Treatment (10 papers), Infective Endocarditis Diagnosis and Management (8 papers), Antibiotic Use and Resistance (8 papers) and Infections and bacterial resistance (6 papers). The work is most often cited by research in Molecular Medicine (1.7k citations), Endocrinology (391 citations), Applied Microbiology and Biotechnology (209 citations), Clinical Biochemistry (376 citations) and Infectious Diseases (1.4k citations). Daniel B. Gregson has collaborated with scholars based in Canada, United States and Australia. Frequent co-authors include Kevin B. Laupland, Deirdre L. Church, Terry Ross, Johann D D Pitout, Sameer Elsayed, Michael D. Parkins, Barbara L. Chow, Gisele Peirano, Jenine R. Leal and John Maynard Conly. Their work appears in journals such as Journal of Clinical Microbiology, BMC Infectious Diseases, Diagnostic Microbiology and Infectious Disease, Clinical Microbiology and Infection and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.